Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Nyse  -  04:00 2022-09-29 pm EDT
35.95 USD   -1.80%
09/20US FDA Commits to Strengthening Infant Formula Supply
MT
09/14Argus Upgrades Perrigo to Buy From Hold; Price Target is $46
MT
09/12Perrigo Says FDA to Review Oral Contraceptive Pill for Over-the-Counter Use in November
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société PERRIGO COMPANY PLC
09/12Perrigo announces joint fda advisory committee to review opill® daily oral contraceptiv..
PR
08/17Perrigo releases statement on recent market trading activity
PR
08/09PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
08/09Perrigo : REPORTS SECOND QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERAT..
PU
08/09Perrigo : Q2 Earnings Snapshot
AQ
08/02Perrigo announces quarterly dividend
PR
07/27Perrigo to release second quarter 2022 financial results on august 9, 2022
PR
07/21Will A Nonprescription Birth Control Pill Be FDA's First Approval Under Its Long-Awaite..
AQ
07/15Perrigo : Independent Auditors' Report - Form 8-K/A
PU
07/15PERRIGO CO PLC Completion of Acquisition or Disposition of Assets, Financial Statement..
AQ
07/14Perrigo Co Plc : Change in Directors or Principal Officers (form 8-K)
AQ
06/01Perrigo promotes alison ives to role of chief scientific officer
PR
05/19Perrigo to present at upcoming consumer investor conferences
PR
05/11PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
05/11Perrigo : Q1 Earnings Snapshot
AQ
05/11Perrigo Co Plc : Change in Directors or Principal Officers, Regulation FD Disclosure, Fina..
AQ
05/11Perrigo reports first quarter fiscal year 2022 financial results from continuing operat..
PR
05/11Perrigo announces planned leadership succession
PR
05/05Perrigo announces quarterly dividend
PR
05/02Perrigo Co Plc : Completion of Acquisition or Disposition of Assets, Regulation FD Disclos..
AQ
05/02Perrigo completes the acquisition of hra pharma
PR
04/28Perrigo : ANNOUNCES EXPECTED TRANSACTION CLOSE DATE OF HRA PHARMA - Form 8-K
PU
04/28Perrigo Co Plc : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
04/28Perrigo announces expected transaction close date of hra pharma
PR
04/27Perrigo to release first quarter 2022 financial results on may 11, 2022
PR
04/20Perrigo : ANNOUNCES CLOSING OF $2.6 BILLION SENIOR SECURED CREDIT FACILITIES - Form 8-K
PU
04/20Perrigo Co Plc : Entry into a Material Definitive Agreement, Termination of a Material Def..
AQ
04/20Perrigo announces closing of $2.6 billion senior secured credit facilities
PR
04/04Perrigo : ANNOUNCES LAUNCH OF PRIVATE NOTES OFFERING - Form 8-K
PU
04/04Perrigo Co Plc : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/04Perrigo announces launch of private notes offering
PR
03/28ALLIANCE PHARMA PLC - Acquisition to access US scar treatment market and expand Kelo-co..
AQ
03/28Perrigo : Non GAAP Disclosure - Form 8-K
PU
03/28Perrigo Co Plc : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits..
AQ
03/28Perrigo announces launch of syndication of new senior secured credit facilities
PR
03/24Perrigo Co Plc : Change in Directors or Principal Officers (form 8-K)
AQ
03/24Perrigo announces cfo retirement and transition plan
PR
03/18Perrigo announces u.s. fda approval for otc use of nasonex 24hr allergy
AQ
03/17Perrigo announces u.s. fda approval for otc use of nasonex® 24hr allergy
PR
03/11Perrigo completes divestiture of latin american businesses
AQ
03/01PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
03/01Perrigo : Q4 Earnings Snapshot
AQ
03/01Perrigo : REPORTS FOURTH QUARTER & FISCAL YEAR 2021 FINANCIAL RESULTS FROM CONTINUING OPER..
PU
02/25Perrigo to present at upcoming investor conferences
PR
02/16Perrigo announces quarterly dividend
PR
02/15Perrigo to release fourth quarter and fiscal year 2021 financial results on march 1, 20..
PR
02/03Perrigo Expands Occupational Health Program with Premise Health's Digital Wellness Cent..
PR
01/04PERRIGO TO PRESENT VIRTUALLY AT THE 40th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
PR
2021Perrigo Co Plc : Entry into a Material Definitive Agreement, Financial Statements and Exhi..
AQ
2021Perrigo Co Plc : Other Events (form 8-K)
AQ
2021Perrigo Announces Voluntary Delisting from the Tel Aviv Stock Exchange (TASE)
PR
2021Perrigo : Immediate Report
PU
2021PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
2021Perrigo, Wendy's fall; RingCentral, Newmont rise
AQ
2021PERRIGO REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS - Form ..
PU
2021Perrigo : Q3 Earnings Snapshot
AQ
2021Perrigo Reports Third Quarter 2021 Financial Results From Continuing Operations
PR
2021Perrigo Co Plc : Change in Directors or Principal Officers (form 8-K)
AQ
2021Rolf A. Classon To Not Stand for Re-Election as Chairman of The Perrigo Board of Direct..
PR
2021Perrigo Announces Quarterly Dividend
PR
2021Perrigo To Release Third Quarter 2021 Financial Results On November 10, 2021
PR
2021Perrigo Co Plc : Entry into a Material Definitive Agreement, Financial Statements and Exhi..
AQ
2021Perrigo Co Plc : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
2021Perrigo : Announces New Consumer Self-Care Americas (CSCA) Leadership
PR
2021Perrigo, Virgin Galactic rise; CarMax, Devon Energy fall
AQ
2021Perrigo : Resolves Irish Tax Assessment for €297 million
PR
2021Perrigo Co Plc : Other Events (form 8-K)
AQ
2021Economic Substance Doctrine : Still Giving Perrigo Heartburn?
AQ
2021Perrigo : HABSONT UNLIMITED COMPANY (Form 8-K)
PU
2021Perrigo Co Plc : Entry into a Material Definitive Agreement, Financial Statements and Exhi..
AQ
2021Sherwin-Williams, PulteGroup fall; Perrigo, Kadmon rise
AQ
2021Perrigo : to Acquire Leading Consumer Self-Care Company, HRA Pharma (Form 8-K)
PU
2021Perrigo Co Plc : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021Perrigo : to Acquire Leading Consumer Self-Care Company, HRA Pharma
PR
2021Perrigo : To Host Virtual Investor Meetings At The 2021 Barclays Global Consumer Staples C..
PR
1  2  3  4Next
Upcoming event on PERRIGO COMPANY PLC